BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 15038597)

  • 1. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.
    Rossi L; Lombardo MF; Ciriolo MR; Rotilio G
    Neurochem Res; 2004 Mar; 29(3):493-504. PubMed ID: 15038597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-dependent oxidative stress and neurodegeneration.
    Rotilio G; Carrì MT; Rossi L; Ciriolo MR
    IUBMB Life; 2000; 50(4-5):309-14. PubMed ID: 11327325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species: stuck in the middle of neurodegeneration.
    Patten DA; Germain M; Kelly MA; Slack RS
    J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
    Singh A; Kukreti R; Saso L; Kukreti S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in the animal model of Menkes' disease involves Bcl-2-linked apoptosis.
    Rossi L; De Martino A; Marchese E; Piccirilli S; Rotilio G; Ciriolo MR
    Neuroscience; 2001; 103(1):181-8. PubMed ID: 11311799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking.
    Greenough MA; Ramírez Munoz A; Bush AI; Opazo CM
    Metallomics; 2016 Sep; 8(9):831-9. PubMed ID: 27397642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
    Giampietro R; Spinelli F; Contino M; Colabufo NA
    Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases.
    Strausak D; Mercer JF; Dieter HH; Stremmel W; Multhaup G
    Brain Res Bull; 2001 May; 55(2):175-85. PubMed ID: 11470313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
    Davies KM; Mercer JF; Chen N; Double KL
    Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, oxidative stress and neurodegeneration.
    Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
    J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.
    Gromadzka G; Tarnacka B; Flaga A; Adamczyk A
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and functions of copper in brain.
    Scheiber IF; Mercer JF; Dringen R
    Prog Neurobiol; 2014 May; 116():33-57. PubMed ID: 24440710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging for mitochondrial metabolism and oxidative stress in mitochondrial diseases and neurodegenerative disorders.
    Ikawa M; Okazawa H; Yoneda M
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129832. PubMed ID: 33358866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper homeostasis and the ubiquitin proteasome system.
    Zhang B; Burke R
    Metallomics; 2023 Mar; 15(3):. PubMed ID: 36822629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.